本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

52.92
-0.2500-0.47%
盤後52.930.0100+0.02%19:44 EDT
成交量:792.30萬
成交額:4.20億
市值:57.68億
市盈率:-51.29
高:53.08
開:53.04
低:52.91
收:53.17
52周最高:53.19
52周最低:1.87
股本:1.09億
流通股本:8,031.64萬
量比:0.35
換手率:9.86%
股息:- -
股息率:- -
每股收益(TTM):-1.0319
每股收益(LYR):-1.1175
淨資產收益率:-29.12%
總資產收益率:-19.94%
市淨率:20.31
市盈率(LYR):-47.35

資料載入中...

2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

SEC問詢函

CORRESP [Cover] - Correspondence
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2023/01/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

重要事件披露

8-K - Current report
2022/12/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/29

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/25

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

重要事件披露

8-K - Current report
2022/08/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals